AI-generated summary
The authors pooled 12 studies of 358 patients to compare low-fluence 1064 nm Q-switched Nd:YAG laser with drugs and other treatments for melasma. They report no significant difference between the laser and drugs alone, and an added benefit when the laser was combined with drugs or intense pulsed light. The authors state that more studies are needed to confirm these combination findings.
- Participants
- 358
- Studies included
- 12
- Who or what was studied
- Patients with melasma, a facial pigmentary disorder
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The authors note that numerous further studies are still needed to verify the combination therapy findings, and the abstract does not describe the quality or certainty of the included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser, Systematic review, Meta-analysis, Confidence interval, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.